Phase 2 trial of Oxford Covid-19 vaccine candidate set to begin from Tuesday

The observer-blind, randomised controlled study to determine the safety and immunogenicity of ''Covishield'' on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune. Serum Institute has partnered with British-Swedish pharma company for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hxWwBC
via IFTTT